Transaktionen anzeigen
Gesundheitswesen

Shield HealthCare has sold a majority interest to Henry Schein

Shield Healthcare has sold a majority ownership position to Henry Schein, Inc. (NASDAQ: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners.

Founded in 1957 and headquartered in Valencia, California, Shield is one of the largest independent value-added distributors of essential medical supplies for patients and caregivers managing care in the home. The company’s diversified product catalog includes durable and consumable medical products for a wide range of patient diagnoses, including incontinence, enteral nutrition, ostomy, urology and advanced wound care. Shield operates across a nationwide footprint to provide superior solutions centered around improving patient outcomes and providing exceptional customer service and patient satisfaction.

Henry Schein is a solutions company for healthcare professionals powered by a network of people and technology. With approximately 24,000 members worldwide, the company’s network of trusted advisors provides over one million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Its business, clinical, technology and supply chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional healthcare clinics as well as other alternate care sites.

Oaklins Intrepid in Los Angeles acted as the exclusive sell-side advisor in this transaction.

DIENSTLEISTUNG
PARTEIEN

Sprechen Sie mit dem Deal Team

Adam Abramowitz

Managing Director
Los Angeles, Vereinigte Staaten
Oaklins Intrepid

Kyle Berkman

Associate Director
Los Angeles, Vereinigte Staaten
Oaklins Intrepid

James Heskett

Associate
Los Angeles, Vereinigte Staaten
Oaklins Intrepid

Transaktionen

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Gesundheitswesen

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Mehr erfahren
Afric Phar has been acquired by Pharma Capital
Gesundheitswesen

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Mehr erfahren
Xiel Limited has been acquired by MIS Healthcare
Private Equity | Gesundheitswesen

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Mehr erfahren